| Gene symbol | EPHA2 | Synonyms | ARCC2, CTPA, CTPP1, CTRCT6, ECK | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | EPH receptor A2 | ||||
| Gene symbol | IL13RA2 | Synonyms | CD213A2, CT19, IL-13R, IL13BP | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | interleukin 13 receptor subunit alpha 2 | ||||
| GTO ID | GTC3699 |
| Trial ID | NCT06186401 |
| Disease | Glioblastoma |
| Altered gene | EPHA2|IL13RA2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | E-SYNC T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase 1 Study of Autologous Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13R alpha2 CAR (E-SYNC) T Cells in Adult Participants With EGFRvIII+ Glioblastoma |
| Year | 2024 |
| Country | United States |
| Company sponsor | Hideho Okada, MD, PhD |
| Other ID(s) | 23704|5U19CA264338-03 |
| Cohort 1 | |||||||||||||
|
|||||||||||||